FDA Adverse Event Injury Summary report: N

ASR ACETABULAR IMPLANT 52

MDR report key: 2834325 · Received November 15, 2012

Report

Report Number
1818910-2012-25183
Event Type
Injury
Date Received
November 15, 2012
Date of Event
July 16, 2012
Report Date
January 28, 2013
Manufacturer
DEPUY INTERNATIONAL
Product Code
KWA
Removal / Correction Number
Z-1749/1816-2011
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
UK
Reporter Occupation
HEALTH PROFESSIONAL

Narratives

Additional Manufacturer Narrative · 1

DEPUY STILL CONSIDERS THE INVESTIGATION CLOSED AT THIS TIME. SHOULD THE PRODUCT AND/OR ADDITIONAL INFORMATION BE RECEIVED, THE INVESTIGATION WILL BE RE-OPENED.

Additional Manufacturer Narrative · 1

THE ASR PLATFORM WAS VOLUNTARILY RECALLED FROM THE MARKET IN AUGUST 2010, AND THE ASR PRODUCT CODES ARE NOW CONSIDERED INACTIVE. FURTHER INVESTIGATION OF THIS INDIVIDUAL INCIDENT WILL NOT BE UNDERTAKEN, AS THERE IS AN ONGOING INVESTIGATION REGARDING THE ROOT CAUSE(S) AND/OR CORRECTIVE ACTIONS. (B)(4). DEPUY CONSIDERS THE INVESTIGATION CLOSED AT THIS TIME. SHOULD THE PRODUCT AND/OR ADDITIONAL INFORMATION BE RECEIVED, THE INVESTIGATION WILL BE RE-OPENED. THE CORRECTION/REMOVAL REPORTING NUMBER LISTED APPLIES TO THE CORRESPONDING PRODUCT CODE SOLD DOMESTICALLY.

Description of Event or Problem · 1

IT WAS REPORTED THAT THE PATIENT HAD A REVISION ON THE ASR XL HIP IMPLANT. THE REASON FOR THE REVISION IS UNEXPLAINED. IT WAS FURTHER REPORTED THAT THE PATIENT EXPERIENCED FUNCTIONAL IMPAIRMENT, NIGHT PAIN, AND RESTRICTED RANGE OF MOTION. IT WAS FURTHER REPORTED THAT BOTH CHROMIUM AND COBALT WERE FOUND IN THE BLOOD OF THE PATIENT.

Description of Event or Problem · 1

ADDITIONAL REASONS FOR REVISION: PAIN, INCREASED COBALT AND CHROMIUM LEVELS, TUMOUR AND FLUID AROUND IMPLANT.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1 ASR ACETABULAR IMPLANT 52 ASR TOTAL HIP REPLACEMENT KWA DEPUY INTERNATIONAL 2334132

Patients

Seq Age Sex Outcome Treatment
1 59 YR Required Intervention